# Raymond L. Comenzo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/raymond-l-comenzo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,493 |
| Field | Amyloidosis: Diagnosis, Treatment, Outcomes |
| h-index | 60 |
| i10-index | 163 |
| Last Known Institution | Tufts Medical Center |
| OpenAlex ID | https://openalex.org/A5033672095 |
| ORCID iD | https://orcid.org/0000-0002-6255-5824 |
| Works | 410 |

## Researcher papers

- [Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma](https://scholariq.org/papers/oral-selinexor-dexamethasone-for-triple-class-refractory-multiple-myeloma/)
- [International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation](https://scholariq.org/papers/international-myeloma-working-group-guidelines-for-the-management-of-multiple/)

## Researcher topics

- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)

## Researcher university

- [Tufts Medical Center](https://scholariq.org/institutions/tufts-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.